Clinical Trial Update: A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study [Phase 2]

View source ↗

Summary

This clinical trial update reports the long-term safety and efficacy of ASP015K in subjects previously enrolled in a Phase 2 rheumatoid arthritis study, with th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASP015K

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED